您的购物车当前为空
Nonsteroidal aromatase inhibitor 1 (Compound 13h) effectively inhibits the enzyme CYP19A1 with an IC50 value of 0.09 nM. Due to its potent inhibitory activity, Nonsteroidal aromatase inhibitor 1 holds promise for research in the field of breast cancer [1].
Nonsteroidal aromatase inhibitor 1 (Compound 13h) effectively inhibits the enzyme CYP19A1 with an IC50 value of 0.09 nM. Due to its potent inhibitory activity, Nonsteroidal aromatase inhibitor 1 holds promise for research in the field of breast cancer [1].
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 25 mg | ¥ 10,600 | 10-14周 | |
| 50 mg | ¥ 13,800 | 10-14周 | |
| 100 mg | ¥ 17,500 | 10-14周 |
Nonsteroidal aromatase inhibitor 1 相关产品
| 产品描述 | Nonsteroidal aromatase inhibitor 1 (Compound 13h) effectively inhibits the enzyme CYP19A1 with an IC50 value of 0.09 nM. Due to its potent inhibitory activity, Nonsteroidal aromatase inhibitor 1 holds promise for research in the field of breast cancer [1]. |
| 体外活性 | Nonsteroidal aromatase inhibitor 1 (0.001 pM-100 pM; 1 h) treatment shows excellent aromatase inhibition activity [1]. Nonsteroidal aromatase inhibitor 1 (1 μM; 48 h) treatment has no impact on MCF-10A or MDA-MB-231 growth [1]. Cell Viability Assay [1] Cell Line: JEG-3 cells Concentration: 0.001 pM-100 pM Incubation Time: 1 hour Result: Showed excellent aromatase inhibition with the IC 50 value of 0.09 nM. Cell Cytotoxicity Assay [1] Cell Line: MCF-10A and MDA-MB-231 cells Concentration: 1 μM Incubation Time: 48 hour Result: Suggested possible limited toxicity in normal breast tissue and little off-target effects. |
| 分子量 | 368.39 |
| 分子式 | C22H16N4O2 |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
评论内容